about
Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse modelsPhase II trial of hu14.18-IL2 for patients with metastatic melanoma.Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy.Mycobacterium bovis Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function.Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream.Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
P2860
Q28392156-E34403DF-98A4-416F-9224-E46653299B9AQ36412879-5F853B3F-2F2B-4D42-A13E-DF2EC45172AEQ38088212-C434D460-BF1F-4628-B755-547D94B8FFDBQ38200527-5E410822-EEC7-4786-B32B-388361A3FBE7Q38604832-A4EFCA21-F4A1-4F03-94A9-1DA34399A385Q39589846-D02CD7B6-6A72-4758-8B5C-B88D36024E6DQ58787920-05FF6688-4F1F-418C-BE10-6E16D2997A1B
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Re-inventing intratumoral immunotherapy for melanoma.
@en
Re-inventing intratumoral immunotherapy for melanoma.
@nl
type
label
Re-inventing intratumoral immunotherapy for melanoma.
@en
Re-inventing intratumoral immunotherapy for melanoma.
@nl
prefLabel
Re-inventing intratumoral immunotherapy for melanoma.
@en
Re-inventing intratumoral immunotherapy for melanoma.
@nl
P2093
P2860
P356
P1433
P1476
Re-inventing intratumoral immunotherapy for melanoma.
@en
P2093
Ernest Borden
Pierre L Triozzi
Ralph J Tuthill
P2860
P304
P356
10.2217/IMT.11.46
P577
2011-05-01T00:00:00Z